A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

PMID- 28858093
DA  - 20170831
DCOM- 20170911
LR  - 20170912
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 35
DP  - 2017 Sep
TI  - Surgical treatment of neovascular glaucoma with Ex-PRESS glaucoma shunt: Case
PG  - e7845
LID - 10.1097/MD.0000000000007845 [doi]
AB  - RATIONALE: Neovascular glaucoma (NVG) is one of the most aggressive types of
      glaucoma, and its abnormal fibrovascular tissue growth on the iris and trabecular
      meshwork may create difficulties to control the intraocular pressure (IOP) and
      perform the operation such as trabeculectomy. PATIENT CONCERNS: Ex-PRESS glaucoma
      shunt has been introduced to serve as one alternative operation for glaucoma, and
      is thought to have the potential advantage of being less traumatic than
      traditional trabeculectomy. The purpose of our study is to evaluate the efficacy 
      and safety of primary Ex-PRESS implantation in eyes with NVG. DIAGNOSES AND
      INTERVENTIONS: This was a retrospective study of four patients with NVG in whom
      primary Ex-PRESS implantation was performed between January 2012 and October
      2016. OUTCOMES: After a mean follow-up of 20.8 +/- 8.9 months (range, 15-34
      months), three of four NVG patients (75.0%) receiving primary Ex-PRESS
      implantation had postoperative IOP under 21 mmHg without any antiglaucoma
      medication control at the last follow-up, but shunt reposition had been performed
      due to failed blebs or recurrent NVG. Besides, the best corrected visual acuity
      at the last follow-up was stabilized or improved in three of four NVG patients
      (75.0%), accompanied with the regression of iris neovascularization. Only one
      patient had self-resolved postoperative hyphema; otherwise, there were no other
      perioperative complications. LESSONS: Primary Ex-PRESS implantation might
      constitute a safe and alternative treatment for patients with NVG. In spite of
      the possible reoperations, the final outcomes were still shown effective after
      shunt reposition.
FAU - Yu, Teng-Chieh
AU  - Yu TC
AD  - aDepartment of Ophthalmology, Taipei City Hospital, Renai Branch bDepartment of
      Health Promotion and Health Education, College of Education, National Taiwan
      Normal University cInstitute of Clinical Medicine, National Yang-Ming University 
      dDepartment of Ophthalmology, School of Medicine, College of Medicine, Taipei
      Medical University eDepartment of Ophthalmology, Shin Kong Wu Ho-Su Memorial
      Hospital, Taipei, Taiwan.
FAU - Tseng, Gow-Lieng
AU  - Tseng GL
FAU - Chen, Chun-Chen
AU  - Chen CC
FAU - Liou, Shiow-Wen
AU  - Liou SW
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - *Glaucoma Drainage Implants
MH  - Glaucoma, Neovascular/*surgery
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Treatment Outcome
PMC - PMC5585487
EDAT- 2017/09/01 06:00
MHDA- 2017/09/12 06:00
CRDT- 2017/09/01 06:00
AID - 10.1097/MD.0000000000007845 [doi]
AID - 00005792-201709010-00017 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Sep;96(35):e7845. doi: 10.1097/MD.0000000000007845.